相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prevention of Learning Deficit in a Down Syndrome Model
Maddalena Incerti et al.
OBSTETRICS AND GYNECOLOGY (2011)
Prenatal NAP plus SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and γ-aminobutyric acid receptors
Joy Vink et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Prevention of Developmental Delays in a Down Syndrome Mouse Model
Laura Toso et al.
OBSTETRICS AND GYNECOLOGY (2008)
NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis
Jorge Busciglio et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current
Tyler K. Best et al.
JOURNAL OF NEUROPHYSIOLOGY (2007)
Vasoactive intestinal peptide in neurodevelopmental disorders: Therapeutic potential
Joanna M. Hill
CURRENT PHARMACEUTICAL DESIGN (2007)
Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice
Andrea Contestabile et al.
HIPPOCAMPUS (2007)
Motor development and neuropsychological patterns in persons with Down syndrome
Stefano Vicari
BEHAVIOR GENETICS (2006)
Learning enhancement with neuropeptides
L Toso et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome
PG Nelson et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
Neonatal mice of the down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation
Nadia Sahir et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Sensory evoked potentials in infants with Down syndrome
YJ Chen et al.
ACTA PAEDIATRICA (2005)
Prevention of alcohol-induced developmental delays and learning abnormalities in a model of fetal alcohol syndrome
M Endres et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome
J Vink et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome
AM Kleschevnikov et al.
JOURNAL OF NEUROSCIENCE (2004)
Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome
PV Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Protective peptides that are orally active and mechanistically nonchiral
DE Brenneman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth
FC Zhou et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome
SH Poggi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome
JM Hill et al.
EXPERIMENTAL NEUROLOGY (2003)
Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model
CY Spong et al.
REGULATORY PEPTIDES (2002)
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation
KB Nelson et al.
ANNALS OF NEUROLOGY (2001)